How is Evolocumab dosed?
The recommended dose of Evolocumab is determined by the patient's specific condition, medical history, and other medications they may be taking. For adults, the initial dose is 420 mg every 2 weeks. For pediatric patients (10-17 years) with heterozygous familial hypercholesterolemia (HeFH) or primary hyperlipidemia, the dose is 400 mg every 2 weeks. It's crucial to follow your doctor's prescription and instructions carefully to ensure the correct dosing. If you have any questions or concerns about your Evolocumab dosage, please consult your healthcare provider.
What is the dosage form of Evolocumab?
Evolocumab is available in the form of a solution.
What medications are contraindication with Evolocumab?
Patients should inform their doctor about other prescription or non-prescription medications they are taking, as drug interactions might occur. It's essential to consult with a healthcare professional before using Evolocumab with other medications, as they can determine the necessary precautions or adjust dosages accordingly.
How is Evolocumab administered?
Evolocumab is administered through injection. It may be given at home under the guidance of a healthcare professional if the patient does not need to be in the hospital or clinic. The medicine comes in three forms: a single-dose prefilled pen (autoinjector), single-dose prefilled syringe, and a single-use Pushtronex system (on-body infusor with prefilled cartridge). Patients will be shown how to prepare and inject the medicine by their doctor, and they should use a different body area each time they give themselves a shot to prevent skin problems from the injections. The injection should not be given on skin areas that are bruised, hard, red, or tender, or have cuts, scrapes, infection, scars, or stretch marks.
What are common precautions when taking Evolocumab?
Common precautions when taking Evolocumab include following the doctor's instructions for preparing and injecting the medicine, using a different body area each time for injection, rotating injection sites to prevent skin problems, avoiding injection into bruised, hard, red, or tender skin or areas with cuts, scrapes, infection, scars, or stretch marks, notifying the doctor for any unusual or allergic reactions to the medicine or other medicines, and not using the medicine in children younger than 10 years old with HoFH and primary hyperlipidemia as its safety and efficacy have not been established. Please consult with a healthcare professional to ensure the appropriate use of Evolocumab and to discuss any specific concerns or questions you may have.